The Value of Preoperative Phase-Contrast MRI in Predicting the Clinical Outcome of Moyamoya Disease after Encephalo-Duro-Arterial Synangiosis Surgery

References

1. 1.↵
   1. Suzuki J,
   2. Takaku A

   . Cerebrovascular “Moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99 doi:10.1001/archneur.1969.00480090076012 pmid:5775283

   CrossRefPubMedWeb of Science
2. 2.↵
   Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir 2012;52:245–66 doi:10.2176/nmc.52.245 pmid:22870528

   CrossRefPubMed
3. 3.↵
   1. Acker G,
   2. Fekonja L,
   3. Vajkoczy P

   . Surgical management of Moyamoya disease. Stroke 2018;49:476–82 doi:10.1161/STROKEAHA.117.018563 pmid:29343587

   FREE Full Text
4. 4.↵
   1. Park SE,
   2. Kim JS,
   3. Park EK, et al

   . Direct versus indirect revascularization in the treatment of Moyamoya disease. J Neurosurg 2018;129:480–89 doi:10.3171/2017.5.JNS17353 pmid:29076784

   CrossRefPubMed
5. 5.↵
   1. Nakashima H,
   2. Meguro T,
   3. Kawada S, et al

   . Long-term results of surgically treated Moyamoya disease. Clin Neurol Neurosurg 1997;99(Suppl 2):S156–61 doi:10.1016/S0303-8467(97)00056-5 pmid:9409428

   CrossRefPubMed
6. 6.↵
   1. Ishii D,
   2. Okazaki T,
   3. Matsushige T, et al

   . Chronic dilatation of superficial temporal artery and middle meningeal artery associated with development of collateral circulation after bypass surgery for Moyamoya angiopathy. World Neurosurg 2018;119:e864–73 doi:10.1016/j.wneu.2018.07.287 pmid:30099176

   CrossRefPubMed
7. 7.↵
   1. Zhao J,
   2. Liu H,
   3. Zou Y, et al

   . Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with Moyamoya disease: a retrospective study of 76 procedures. Exp Ther Med 2018;15:3570–76 doi:10.3892/etm.2018.5850 pmid:29545885

   CrossRefPubMed
8. 8.↵
   1. Spilt A,
   2. Box FM,
   3. van der Geest RJ, et al

   . Reproducibility of total cerebral blood flow measurements using phase-contrast magnetic resonance imaging. J Magn Reson Imaging 2002;16:1–5 doi:10.1002/jmri.10133 pmid:12112496

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Henriksen OM,
   2. Larsson HBW,
   3. Hansen AE, et al

   . Estimation of intersubject variability of cerebral blood flow measurements using MRI and positron emission tomography. J Magn Reson Imaging 2012;35:1290–99 doi:10.1002/jmri.23579 pmid:22246715

   CrossRefPubMed
10. 10.↵
    1. Neff KW,
    2. Horn P,
    3. Schmiedek P, et al

    . 2D cine phase-contrast MRI for volume flow evaluation of the brain-supplying circulation in Moyamoya disease. AJR Am J Roentgenol 2006;187:W107–15 doi:10.2214/AJR.05.0219 pmid:16794123

    CrossRefPubMed
11. 11.↵
    1. Khan N,
    2. Lober RM,
    3. Ostergren L, et al

    . Measuring cerebral blood flow in Moyamoya angiopathy by quantitative magnetic resonance angiography noninvasive optimal vessel analysis. Neurosurgery 2017;81:921–27 doi:10.1093/neuros/nyw122 pmid:28204602

    CrossRefPubMed
12. 12.↵
    1. Gao F,
    2. Zhao W,
    3. Zheng Y, et al

    . Phase-contrast magnetic resonance imaging analysis of cerebral hyperperfusion syndrome after surgery in adult patients with Moyamoya disease. World Neurosurg 2019;129:e48–55 doi:10.1016/j.wneu.2019.04.191 pmid:31051310

    CrossRefPubMed
13. 13.↵
    1. Dusick JR,
    2. Gonzalez NR,
    3. Martin NA

    . Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures. Neurosurgery 2011;68:34–43; discussion 43 doi:10.1227/NEU.0b013e3181fc5ec2 pmid:21150753

    CrossRefPubMed
14. 14.↵
    1. Houkin K,
    2. Nakayama N,
    3. Kuroda S, et al

    . How does angiogenesis develop in pediatric Moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 2004;20:734–41 doi:10.1007/s00381-004-0971-x pmid:15197570

    CrossRefPubMed
15. 15.↵
    1. Nael C,
    2. Kronsteiner N,
    3. Schindler E, et al

    . Standardized time to peak in ischemic and regular cerebral tissue measured with perfusion MR imaging. AJNR Am J Neuroradiol 2004;25:945 pmid:15205128

    PubMed
16. 16.↵
    1. Matsushima T,
    2. Inoue T,
    3. Suzuki SO, et al

    . Surgical treatment of Moyamoya disease in pediatric patients: comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992;31:401–05 doi:10.1227/00006123-199209000-00003 pmid:1407421

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Zarrinkoob L,
    2. Wåhlin A,
    3. Ambarki K, et al

    . Blood flow lateralization and collateral compensatory mechanisms in patients with carotid artery stenosis. Stroke 2019;50:1081–88 doi:10.1161/STROKEAHA.119.024757 pmid:30943887

    CrossRefPubMed
18. 18.↵
    1. Ando T,
    2. Sekine T,
    3. Murai Y, et al

    . Multiparametric flow analysis using four-dimensional flow magnetic resonance imaging can detect cerebral hemodynamic impairment in patients with internal carotid artery stenosis. Neuroradiology 2020;62:1421–31 doi:10.1007/s00234-020-02464-2 pmid:32518970

    CrossRefPubMed
19. 19.↵
    1. Zhu F,
    2. Qian Y,
    3. Xu B, et al

    . Quantitative assessment of changes in hemodynamics of the internal carotid artery after bypass surgery for Moyamoya disease. J Neurosurg 2018;129:677–83 doi:10.3171/2017.5.JNS163112 pmid:29053072

    CrossRefPubMed
20. 20.↵
    1. Arakawa S,
    2. Kamouchi M,
    3. Okada Y, et al

    . Ultrasonographically predicting the extent of collateral flow through superficial temporal artery-to-middle cerebral artery anastomosis. AJNR Am J Neuroradiol 2003;24:886–91 pmid:12748089

    PubMed